Contact Us

Paxil
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

Did patient hurt themselves during or after taking the drug?

Did patient become violent during or after taking the drug?

Was suicide attempted?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Did loved one commit suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

If patient did commit suicide, what was the method of suicide?

Please describe violent or suicidal behavior:

If you ever tried to stop taking Paxil and experienced withdrawal, please describe the withdrawal side effects:

Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


GlaxoSmithKline Reaches Paxil Settlement

GlaxoSmithKline agrees to $63.8 million settlement in Paxil lawsuit

Nov 1, 2006 | AP

GlaxoSmithKline PLC has agreed to pay $63.8 million to settle a lawsuit's claims that it promoted its antidepressant drug Paxil for use by children and adolescents while withholding negative information about the medication's safety and effectiveness.

Actual payments to consumers will depend on the amount of claims. If there is not enough money to pay all the claims, consumers will get only a portion of the amount they otherwise could have gotten.

Madison County Associate Judge Ralph Mendelsohn approved the settlement on Oct. 6 and unsealed it Oct. 27. He will hold a hearing March 9 on whether the settlement is fair and whether the plaintiffs' attorneys are entitled to the fee they request. Messages were left Wednesday with U.S. representatives of London-based GlaxoSmithKline PLC.


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo